Skip to search.
 FTSE 100 Down 0.04%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.51 Down 0.24(5.05%) 27 Feb 21:00
|After Hours: : 4.50 Down 0.01 (0.22%) 28 Feb 00:57
Add to Portfolio
Prev Close:4.75
Open:4.73
Bid:N/A
Ask:5.15 x 10000
1y Target Est:7.58
Beta:-4.33
Next Earnings Date: 2-Mar-15ARNA Earnings announcement
Day's Range:4.47 - 4.75
52wk Range:3.26 - 7.24
Volume:6,894,611
Avg Vol (3m):8,197,080
Market Cap:992.71m
P/E (ttm):N/A
EPS (ttm):-0.24
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNADown 5.05%992.71m
GSKDown 0.88%114.07b
OREXDown 3.92%696.31m
RHHBYUp 0.80%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):30.49
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.25
Quarterly EPS Est (Dec-14) :-0.12
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.94

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback